SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-21-021750
Filing Date
2021-11-04
Accepted
2021-11-04 16:03:40
Documents
54
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q blcm-20210930.htm   iXBRL 10-Q 1536504
2 EX-31.1 a2021q3exhibit311.htm EX-31.1 11803
3 EX-32.1 a2021q3exhibit321.htm EX-32.1 6017
  Complete submission text file 0001628280-21-021750.txt   6304665

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blcm-20210930.xsd EX-101.SCH 40335
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT blcm-20210930_cal.xml EX-101.CAL 53343
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT blcm-20210930_def.xml EX-101.DEF 213266
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blcm-20210930_lab.xml EX-101.LAB 512260
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blcm-20210930_pre.xml EX-101.PRE 342574
9 EXTRACTED XBRL INSTANCE DOCUMENT blcm-20210930_htm.xml XML 976816
Mailing Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098
Business Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36783 | Film No.: 211379847
SIC: 2834 Pharmaceutical Preparations